Authors: Gu, JX Dirr, MJ Wang, YL Soper, DL De, B Wos, JA Johnson, CR

Citation: Jx. Gu et al., An efficient synthesis of 3-hetero-13,14-dihydro prostaglandin F-1 alpha analogues, ORG LETT, 3(5), 2001, pp. 791-794

Authors: Soper, DL Milbank, JBJ Mieling, GE Dirr, MJ Kende, AS Cooper, R Jee, WSS Yao, W Chen, JL Bodman, M Lundy, MW De, B Stella, ME Ebetino, FH Wang, YL deLong, MA Wos, JA

Citation: Dl. Soper et al., Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis, J MED CHEM, 44(24), 2001, pp. 4157-4169

Authors: Soper, DL Milbank, JBJ Mieling, GE Dirr, MJ Kende, AS Chen, R Bodman, M Lundy, MW De, B Stella, ME Ebetino, FH Wang, YL deLong, MA Wos, JA

Citation: Dl. Soper et al., Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis. (vol 44, pg 4157, 2001), J MED CHEM, 44(24), 2001, pp. 4307-4307

Authors: Wang, YL Wos, JA Dirr, MJ Soper, DL deLong, MA Mieling, GE De, B Amburgey, JS Suchanek, EG Taylor, CJ

Citation: Yl. Wang et al., Design and synthesis of 13,14-dihydro prostaglandin F-1 alpha analogues aspotent and selective ligands for the human FP receptor, J MED CHEM, 43(5), 2000, pp. 945-952

Authors: Wang, YL Soper, DL Dirr, MJ deLong, MA De, B Wos, JA

Citation: Yl. Wang et al., The synthesis and human FP receptor binding affinity of 13,14-dihydro prostaglandin F-1 alpha sulfonamides: Potential treatments for osteoporosis, CHEM PHARM, 48(9), 2000, pp. 1332-1337